Khyber Medical University Peshawar
kmu.edu.pkLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
47
Active
15
Phase 3
2
Total enrollment
17,415
Pipeline matrix
Showing 8 of 8 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Psilocybin | — | — | — | — | 2 | ||
| Selective Serotonin Reuptake Inhibitor | — | — | — | — | — | 1 | |
| Alendronate, Ibandronate; Risedronate | — | — | — | — | — | 1 | |
| Teriparatide | — | — | — | — | — | 1 | |
| Listerine Mouthwash Product | — | — | — | — | — | 1 | |
| Chlorhexidine mouthwash | — | — | — | — | — | 1 | |
| Conventional Chemotherapy | — | — | — | — | — | 1 | |
| Acetyl-l-carnitine | — | — | — | — | — | 1 |
Next readouts
- 2023-07-31
- 2025-11-29
- 2026-03-25
- 2026-07-30
- 2027-10-22
Top conditions
- Dental Plaque3
- PCOS3
- Obesity3
- Gestational Diabetes2
- Inflammation2
- Insulin Resistance2
- Stunting2
- Wasting2
Frequently asked questions about Khyber Medical University Peshawar
- How many clinical trials does Khyber Medical University Peshawar have on ClinicalTrials.gov?
- Khyber Medical University Peshawar is listed as the lead sponsor on 47 clinical trials in ClinicalTrials.gov, 15 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Khyber Medical University Peshawar's trials are in Phase 3?
- 2 of Khyber Medical University Peshawar's trials are in Phase 3, spread across 8 active drug programs.
- What therapeutic areas does Khyber Medical University Peshawar focus on?
- Khyber Medical University Peshawar's most-studied conditions on ClinicalTrials.gov are Dental Plaque, PCOS, Obesity, Gestational Diabetes, Inflammation.
- When are Khyber Medical University Peshawar's next clinical trial readouts?
- Khyber Medical University Peshawar has 5 upcoming primary-completion readouts tracked here; the soonest is “Impact Of Intermittent And Water-Only Fasting On Gene Expression And Tumor Markers In Breast Cancer”, expected around 2023-07-31.